Champions Oncology (CSBR) Change in Account Payables (2010 - 2026)

Champions Oncology's Change in Account Payables history runs 17 years deep, the most recent figure standing at $1.3 million for Q2 2026.

• In Q2 2026, Change in Account Payables rose 307.33% year-over-year to $1.3 million; the TTM figure through Apr 2026 stood at $2.6 million (up 246.26% YoY), while the FY2026 annual figure was $2.6 million, up 246.26% from the prior year.
• Change in Account Payables for Q2 2026 stood at $1.3 million, up from -$437000.0 in the prior quarter.
• The five-year high for Change in Account Payables was $2.1 million in Q4 2022, with the low at -$1.2 million in Q4 2023.
• The 5-year median for Change in Account Payables is $17000.0 (2024), against an average of $178166.7.
• Peak annual rise in Change in Account Payables reached 1443.28% in 2022, while the deepest fall reached 635.57% in 2022.
• Champions Oncology's Change in Account Payables stood at $2.1 million in 2022, then sank by 159.19% to -$1.2 million in 2023, then surged by 68.79% to -$382000.0 in 2024, then jumped by 443.19% to $1.3 million in 2025, then dropped by 2.9% to $1.3 million in 2026.
• Business Quant data shows CSBR's Change in Account Payables at $1.3 million in Q2 2026, -$437000.0 in Q1 2026, and $1.3 million in Q4 2025.